Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 273
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Silo Wellness Appoints Phytomedicine Business Leader as Board Member
PharmaTher Announces Submission of IND Application with the FDA for Phase...
The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for...
Thomas B. Roberts: “Psychedelic Directions, Where Does Your Mind Alight?”
Psychedelic Bulletin: Experts Weigh in on Psilocybin vs. SSRIs; GH Research...
PTSF55 – Creativity, Group Ceremony, and Astral Projection
PharmaTher Provides Update on Psychedelic Product Programs
Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray...
Albert Labs Appoints Mackie Research As Lead Agent For Private Placement...
New England Journal of Medicine publishes exploratory study showing signals of...
Load more